Prognostic value of dipyridamole SPECT imaging in low-risk patients after myocardial infarction

Journal of Nuclear Cardiology

Volumn 8, Issue 2, 2001, Pages 136-143

  Chiamvimonvat, Vera ^a   Goodman, Shaun G ^b   Langer, Anatoly ^b   Barr, Aiala ^b   Freeman, Michael R ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Angiography; Dipyridamole; Myocardial infarction; Scintigraphy

Indexed keywords

ACETYLSALICYLIC ACID; DIPYRIDAMOLE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; THALLIUM 201; WARFARIN;

ADULT; AGED; ANGIOGRAPHY; ANGIOPLASTY; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY OBSTRUCTION; CORONARY RISK; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DISEASE COURSE; DOUBLE BLIND PROCEDURE; EXERCISE ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; FUTUROLOGY; HEART DEATH; HEART INFARCTION; HEART MUSCLE PERFUSION; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; REVASCULARIZATION; RISK ASSESSMENT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STATISTICAL ANALYSIS; TREATMENT PLANNING; UNSTABLE ANGINA PECTORIS;

EID: 0035032958     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1067/mnc.2001.112099     Document Type: Article

References (34)

1. Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994
2. Recent trends in acute coronary heart disease-mortality, morbidity, medical care and risk factors
3. Relative importance of improved hospital treatment and primary prevention. Results from 20 years of the Myocardial Infarction Register, Goteborg, Sweden
4. Trends in acute myocardial infarction and coronary heart disease death in the United States
5. Myocardial infarction patients in the 1990s-their risk factors, stratification and survival in Canada: The Canadian Assessment of Myocardial Infarction (CAMI) Study
6. Cumulative meta-analysis of therapeutic trials for myocardial infarction
7. The effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease: The Stanford Coronary Risk Intervention Project (SCRIP)
8. The effects of tissue plasminogen activator, streptokinase or both on coronary artery patency, ventricular function, and survival after acute myocardial infarction
9. One-year results of the Thrombolysis in Myocardial Infarction Investigation (TIMI) phase II trial
10. Prediction of cardiac event after uncomplicated myocardial infarction: A prospective study comparing predischarge exercise thallium-201 scintigraphy and coronary angiography
11. Usefulness of residual ischemic myocardium within prior infarct zone for identifying patients at high risk late after acute myocardial infarction
12. Prognostic value of intravenous dipyridamole-thallium scintigraphy after acute myocardial ischemic events
13. Prognostic value of thallium-201 myocardial perfusion imaging
14. Dipyridamole-thallium-201 scintigraphy in the prediction of future cardiac events after acute myocardial infarction
15. Dipyridamole thallium-201 scintigraphy in the early post-infarction period
16. Limited prognostic value of thallium-201 exercise treadmill testing early after myocardial infarction in patients treated with thrombolysis
17. Detection and significance of myocardial ischemia in stable patients after recovery from an acute coronary event
18. Limited usefulness of exercise testing and thallium scintigraphy in evaluation of ambulatory patients several months after recovery from an acute coronary event: Implications for management of stable coronary heart disease
19. Prognostic value of predischarge low-level exercise thallium testing after thrombolytic treatment of acute myocardial infarction
20. Strategies for prognostic assessment of uncomplicated first myocardial infarction: 5-year follow-up study
21. 201T1 tomography in patients treated with thrombolytic therapy during acute myocardial infarction
22. Use of exercise technetium-99m sestamibi SPECT imaging to detect residual ischemia and for risk stratification after acute myocardial infarction
23. Early dipyridamole (99m)TC-sestamibi single photon emission computed tomographic imaging 2 to 4 days after acute myocardial infarction predicts in-hospital and post-discharge cardiac event: Comparison with submaximal exercise imaging
24. Value of thallium-201 imaging in detecting adverse cardiac events after myocardial infarction and thrombolysis: A follow-up of 100 consecutive patients
25. Role of adenosine thallium-201 tomography for defining long-term risk in patients after acute myocardial infarction
26. Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy: Veterans Affairs Non-Q-Wave Infarction Strategies in Hospital Investigators
27. Randomised double-blind trial of fixed low-dose warfarin with aspirin after myocardial infarction
28. Quantitative analysis of exercise SPECT thallium in the detection of coronary disease
29. Clinical comparison of 180-degree and 360-degree data collection of technetium 99m sestamibi SPECT for detection of coronary artery disease
30. Quantitative rotational thallium-201 tomography for identifying and localizing coronary artery disease
31. Clinical application of rest thallium-201/stress technetium-99m sestamibi dual isotope myocardial perfusion single-photon emission computed tomography
32. Comparison of symptomlimited and low level exercise tolerance tests early after myocardial infarction
33. Unmasking potential myocardial ischemia with dipyridamole-thallium imaging in patients with normal submaximal exercise thallium tests
34. Safety of early intravenous dipyridamole technetium 99m sestamibi SPECT myocardial perfusion imaging after uncomplicated first myocardial infarction